From: Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
SN
LE score
Mol.Wt.
HBA
HBD
Log P
39
− 0.13
785.09
8
2
4.49
N1
− 0.21
863.99
4.25
N2
− 0.23
819.54
4.14
N3
− 0.22
830.09
10
4.39
N4
815.12
9